-
NIH officials discuss agency’s Long COVID clinical trials, respond to critiques
“We understand the frustration and respect it completely,” said NIAID program officer and TLC leader Joseph Breen, when asked about the more than a year that’s gone between RECOVER-TLC trials’ announcement and enrolling participants. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSTrending
Policy & Advocacy
-
Q&A: Eric Topol on Long Covid clinical trials, RECOVER funding, what he’s looking forward to in 2024
-
What’s happening this week, January 2
-
Long Covid advocates send “unhappy holiday” cards to their representatives
-
#MEAction co-founder Beth Mazur passes away
-
Policy experts, scientists, disability groups urge Biden to address the Long Covid crisis
-
HHS gave million-dollar grants to nine Long Covid clinics; here’s how they plan to use the funding
Science
-
No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential
-
Research updates, August 12
-
Three clinical trials for Long COVID are testing JAK inhibitors to treat immune dysregulation
-
Research updates, August 5
-
Clinical trials are testing cancer drug rapamycin for Long COVID and ME
-
Research updates, July 29
Covid-19
-
We won’t avoid the next pandemic. But we can still prepare.
-
National COVID-19 trends, February 4
-
The “pandemic of abandonment”: Navigating friendships five years into COVID-19
-
National COVID-19 trends, January 28
-
Some U.S. COVID-19 data are down amid “pause” to federal health communications
-
Long COVID is a smoldering threat to wildland firefighters
Health
-
Climate change is worsening symptoms of Long Covid and POTS. Here’s how people are navigating it.
-
Double trouble: Hypermobility may increase Long Covid risk
-
In South Africa, Long Covid is an afterthought to Tuberculosis
-
Frustrations, denials, long drives: Immunocompromised people can’t access a lifesaving Covid-19 drug
-
Olympics volunteers resign over lack of Covid-19 precautions
-
How the Apricot Tree Café became a leader in clean indoor air
